• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于环吡酮胺溶液和乳膏疗效及耐受性的双盲对照研究精选]

[Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].

作者信息

Beyer M

出版信息

Arzneimittelforschung. 1981;31(8A):1378-81.

PMID:7028051
Abstract

The results of selected double-blind comparative studies, which had been conducted outside the Federal Republic of Germany, are reported on in summary. In these trials, a 1% solution of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone, 2-aminoethanol salt (ciclopiroxolamine, Cic, Hoe 296, Batrafen) was compared with a 1% solution of tolnaftate (2 studies) and clotrimazole (1 study), respectively, and a 1% Cic cream was compared with a 1% clotrimazole cream (2 studies). The three compounds showed a similar efficacy against the respective groups of sensitive organisms. Particular characteristics and advantages of Cic which were observed with other modes of administration in studies conducted later on, had not been the objective of the trials reported here.

摘要

以下是对在德意志联邦共和国境外进行的部分双盲对比研究结果的简要报告。在这些试验中,分别将6 - 环己基 - 1 - 羟基 - 4 - 甲基 - 2(1H)-吡啶酮2 - 氨基乙醇盐(环吡酮胺,Cic,Hoe 296,巴特芬)的1%溶液与托萘酯的1%溶液(2项研究)和克霉唑的1%溶液(1项研究)进行比较,并且将1%环吡酮胺乳膏与1%克霉唑乳膏进行比较(2项研究)。这三种化合物对各自的敏感生物体组显示出相似的疗效。环吡酮胺在后来进行的研究中通过其他给药方式观察到的特殊特性和优势,并非此处所报告试验的目标。

相似文献

1
[Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].[关于环吡酮胺溶液和乳膏疗效及耐受性的双盲对照研究精选]
Arzneimittelforschung. 1981;31(8A):1378-81.
2
[Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)].环吡酮胺治疗皮肤真菌病的非欧洲开放性临床疗效及耐受性研究(作者译)
Arzneimittelforschung. 1981;31(8A):1381-5.
3
[Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
Arzneimittelforschung. 1981;31(8A):1360-5.
4
[Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
Arzneimittelforschung. 1981;31(8A):1376-8.
5
[Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].[在德国进行的1%环吡酮胺聚乙二醇400溶液治疗皮肤真菌病的开放临床试验/缩短疗程的研究(作者译)]
Arzneimittelforschung. 1981;31(8A):1373-6.
6
[Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].从皮肤科制剂中释放出环吡酮胺(作者译)
Arzneimittelforschung. 1981;31(8A):1332-7.
7
Topical treatment of dermatophytoses and candidoses.皮肤癣菌病和念珠菌病的局部治疗。
Practitioner. 1975 Mar;214(1281):412-7.
8
[Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
Arzneimittelforschung. 1981;31(8A):1366-8.
9
[On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
Arzneimittelforschung. 1981;31(8A):1369-72.
10
[Clinical study with Hoe 296 in glabrous skin dermatophytosis and pityriasis versicolor].[Hoe 296用于无毛皮肤皮肤癣菌病和花斑糠疹的临床研究]
Rev Invest Salud Publica. 1974 Oct-Dec;34(4):175-81.

引用本文的文献

1
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.环吡酮胺:作为一种局部抗真菌药物,其近期的非临床和临床数据。
Drugs. 2010 Nov 12;70(16):2133-52. doi: 10.2165/11538110-000000000-00000.